로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP Cytokines Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2
0
There is no goods in the shopping cart !
My Cart|Secure Checkout
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > TRAIL

TRAIL

Brief Information

Name:Tumor necrosis factor ligand superfamily member 10
Target Synonym:CD253,Apo-2 ligand,TNFSF10,TNF Superfamily Member 10,APO2L,Tumor Necrosis Factor Apoptosis-Inducing Ligand Splice Variant Delta,Tumor Necrosis Factor Ligand Superfamily Member 10,Tumor Necrosis Factor (Ligand) Family, Member 10,TNF-Related Apoptosis Inducing Ligand TRAIL,TNF-Related Apoptosis-Inducing Ligand,Tumor Necrosis Factor Ligand 6A,CD253 Antigen,Protein TRAIL,TNLG6A,TL2,TRAIL,Apo-2L,Tumor Necrosis Factor (Ligand) Superfamily, Member 10,Chemokine Tumor Necrosis Factor Ligand Superfamily M
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 1 Clinical

Product ListCompare or Buy

Product> Filter Results
By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
TRL-H5243 Human Human TRAIL / TNFSF10 Protein, His Tag, active trimer (MALS verified)
TRL-H5243-sds
TRL-H5263 Human Human TRAIL / TNFSF10 Protein, Fc Tag, active trimer (MALS verified)
TRL-H5263-sds
ACRO Quality

Part of Bioactivity data

TRL-H5259-BLI
TRAIL ELISA

Immobilized Human Osteoprotegerin, His Tag (Cat. No. TNB-H5220) at 5 μg/mL (100 μL/well) can bind Human TRAIL, Mouse IgG2a Fc Tag (Cat. No. TRL-H5259) with a linear range of 0.78-25 ng/mL (QC tested).

Protocol

Synonym Name

Apo-2L,TRAIL,CD253,TNFSF10,Apo-2 ligand

Background

TRAIL, also known as  TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL, TNLG6A and TNF superfamily member 10. The TRAIL gene as a drug target, induces apoptosis. Its activity may be modulated by binding to the decoy receptors TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4 and TNFRSF11B/OPG that cannot induce apoptosis. TRAIL also binds the receptors DcR1 and DcR2, which do not contain a cytoplasmic domain (DcR1) or contain a truncated death domain (DcR2). DcR1 functions as a TRAIL-neutralizing decoy-receptor. The cytoplasmic domain of DcR2 is functional and activates NFkappaB. In cells expressing DcR2, TRAIL binding therefore activates NFkappaB, leading to transcription of genes known to antagonize the death signaling pathway and/or to promote inflammation.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
AS-1501 AS-1501 Phase 1 Clinical Shenzhen Zhongke Ai Shen Pharmaceutical Co Ltd Liver Failure; Hepatitis; Chemical and Drug Induced Liver Injury, Chronic; Chemical and Drug Induced Liver Injury; Hepatic Insufficiency Details

This web search service is supported by Google Inc.

totop
Call us
우리에게 전화하세요
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521
Email
이메일
order.kr@acrobiosystems.com
Fax
팩스
+1 888-377-6111
Address
주소
서울 성동구 왕십리로10길 6 서울숲비즈포레 703
회사명
아크로바이오 주식회사
사업자 등록번호
186-88-02858
대표자
CHEN YIDING
사업장주소
서울특별시 송파구 중대로12길 10-20, 1층 셀렉티드송파(가락동)
linkedin twitter facebook youtube

문의

Copyright © 2017 ACROBiosystems. All Rights Reserved
Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap